Methyl Alcohol

Methyl Alcohol

SCHEMBL4213069

CC(C)(C)OC(C)(C)C.CO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
TSHR P16473 2/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL1172804 0.95 ALDH1A1 (0.43) ALDH1A1TSHRTDP1
Hydrogen Peroxide SCHEMBL20917732 0.90 ALDH1A1 (0.46) ALDH1A1TSHRTDP1
SCHEMBL28365346 0.89 ALDH1A1 (0.46) ALDH1A1TSHRTDP1
SCHEMBL8913 0.89
SCHEMBL27555152 0.86 ALDH1A1 (0.43) ALDH1A1TSHRTDP1
Ethane SCHEMBL353672 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
Methane SCHEMBL30637 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
Water SCHEMBL8067978 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
SCHEMBL31678023 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
Potassium SCHEMBL183183 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020134727-A1 TETRAPEPTIDE COMPOUND, PREPARATION METHOD AND USE THEREOF 兰州大学 2020-07-02 WO claimed
CN-111201225-B Coumarin-like ring compound as MEK inhibitor and application thereof 基石药业 2021-11-05 CN disclosed
CN-107074829-B For inhibiting microsomal prostaglandin E2Novel methyl-piperidine compounds of synthetase-1 伊莱利利公司 2020-11-13 CN disclosed
WO-2020134727-A1 TETRAPEPTIDE COMPOUND, PREPARATION METHOD AND USE THEREOF 兰州大学 2020-07-02 WO disclosed
WO-2020119583-A1 METHOD FOR PREPARING PYRIDINAMINE COMPOUND 江苏中旗科技股份有限公司 2020-06-18 WO disclosed
CN-110352187-A ENAMIDE PROCESS 桑诺维恩药品公司 2019-10-18 CN disclosed
CN-110270360-A The method for preparing oligomerisation catalyst 赢创德固赛有限公司 2019-09-24 CN disclosed
CN-108774100-A A kind of tert-butyl alcohol and methanol prepare the integrated processes of methyl tertiary butyl ether(MTBE) and isobutene 信汇科技有限公司 2018-11-09 CN disclosed
CN-108728181-A A kind of high-clean gasoline component and its application 王学明 2018-11-02 CN disclosed
CN-108728181-A A kind of high-clean gasoline component and its application 王学明 2018-11-02 CN disclosed
EP-1846141-B1 PROCESS FOR INHIBITING DEPOSITION OF SOLIDS FROM A GASEOUS STREAM OBTAINED FROM A HYDROFORMYLATION REACTION MIXTURE SHELL INT RESEARCH (NL) 2008-05-07 EP disclosed
US-7321044-B2 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens SCHERING AKTIENGESELLSCHAFT (DE) 2008-01-22 US disclosed
EP-1846141-A2 PROCESS FOR INHIBITING DEPOSITION OF SOLIDS FROM A GASEOUS STREAM OBTAINED FROM A HYDROFORMYLATION REACTION MIXTURE Shell Internationale Research Maatschappij B.V. (NL) 2007-10-24 EP disclosed
EP-1843997-A1 TREATMENT OF AN AQUEOUS MIXTURE CONTAINING AN ALKYLENE OXIDE WITH AN ION EXCHANGE RESIN Shell Internationale Research Maatschappij B.V. (NL) 2007-10-17 EP disclosed
US-20060189831-A1 Process for inhibiting deposition of solids from a gaseous stream SHELL OIL COMPANY 2006-08-24 US disclosed
US-20060189833-A1 Treatment of an aqueous mixture containing an alkylene oxide with an ion exchange resin SHELL OIL COMPANY 2006-08-24 US disclosed
WO-2006083942-A2 PROCESS FIR INHIBITING DEPOSITION OF SOLIDS FROM A GASEOUS STREAM OBTAINED FROM A HYDROFORMYLATION REACTION MIXTURE SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2006-08-10 WO disclosed
WO-2006083896-A1 TREATMENT OF AN AQUEOUS MIXTURE CONTAINING AN ALKYLENE OXIDE WITH AN ION EXCHANGE RESIN SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2006-08-10 WO disclosed
CN-1602298-A Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens SCHERING AG (DE) 2005-03-30 CN disclosed
US-20030162974-A1 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens SCHERING AG (DE) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162974-A1 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens CYP19A1, HSD17B11, SULT1E1 ALDH1A1 243/4885TSHR 2345/4885TDP1 4412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.